RainMed Medical Group
5
0
0
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
A Multi-center, Real-World Clinical Trial of caIMR on Two Specific Kinds of Patients.
Role: collaborator
Angio-IMR and Cardiac MR-derived MVO in STEMI Patients
Role: collaborator
Clinical Trial for Evaluating the Effectiveness and Safety of Online caIMR in STEMI Patients
Role: collaborator
Prognostic Implication of Angiography-Derived IMR in STEMI Patients
Role: collaborator
A Prospective, Multi-center Clinical Trial for Evaluating the Effectiveness and Safety of Online Coronary Angiography-Derived Index of Microcirculatory Resistance (caIMR)
Role: collaborator
All 5 trials loaded